Xtx Topco LTD Halozyme Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $800,297 - $966,458	21,950 Added 334.91%	28,504 $1.09 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $198,455 - $253,901	6,554 New	6,554 $236,000
Q2 2021 Aug 12, 2021	SELL	$38.84 - $51.31 $538,866 - $711,874	-13,874 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $548,161 - $713,817	13,874 New	13,874 $578,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.